The government expenditure on R&D in medical and health sciences in Italy for 2023 stood at approximately 1.37 billion USD PPP. Forecasted values show a steady annual increase from 2024 to 2028, with an increment of 0.05 billion USD PPP each year. This equates to a year-on-year growth rate of about 3.52%. The compound annual growth rate (CAGR) over the five-year forecast period from 2024 to 2028 is expected at 3.52%, indicating consistent government investment in this sector.
Future trends to watch for include:
- A potential increase in R&D investment due to emerging healthcare challenges and technological advancements.
- The impact of government policy changes on healthcare funding priorities.
- Evolving collaborations between public and private sectors in medical R&D.
